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Introduction
The spindle assembly checkpoint, or mitotic checkpoint, co­
ordinates mitotic timing with chromosome–spindle inter­
actions during mitosis, restricting mitotic exit to cells that have 
achieved biorientation of all their chromosomes (Musacchio 
and Salmon, 2007). Cells in which the checkpoint is artifi­
cially inactivated undergo precocious mitotic exit in the pres­
ence of unattached or incorrectly attached chromosomes. 
Alterations of checkpoint function might be relevant for tumor 
development, possibly by rendering cells more susceptible to 
the development of aneuploidies and to consequent genetic 
instability (Kolodner et al., 2011).
Bub1 (budding uninhibited by benzimidazole 1) was origi­
nally characterized as a conserved component of the spindle as­
sembly checkpoint (Hoyt et al., 1991; Taylor and McKeon, 1997; 
Musacchio and Salmon, 2007). More recently, Bub1 was also 
shown to play a function in chromosome alignment (Johnson 
et al., 2004; Meraldi and Sorger, 2005; Windecker et al., 2009). 
Precisely how Bub1 performs these functions at the molecular 
level is unclear (Bolanos­Garcia and Blundell, 2011; Elowe, 
2011). Bub1 localization at kinetochores, in which it displays 
slow exchange dynamics during mitosis (Howell et al., 2004; 
Shah et al., 2004), might be important or even essential for its 
functions. Bub1 phosphorylates Cdc20, the target of the check­
point, on several sites, promoting its ability to engage in an in­
hibitory complex with other checkpoint proteins (Tang et al., 
2004a). Moreover, Bub1 promotes kinetochore recruitment of 
other checkpoint proteins, including Mad1, Mad2, Mad3/BubR1 
(Bub1 related), and Bub3. Such recruitment is in turn believed to 
be important for the activity of these proteins (Sharp­Baker and 
Chen, 2001; Chen, 2002; Johnson et al., 2004; Vigneron et al., 
2004; Meraldi and Sorger, 2005; Boyarchuk et al., 2007; Rischitor 
et al., 2007; Klebig et al., 2009; Storchová et al., 2011). Bub1 
also phosphorylates H2A (histone 2A), promoting the recruit­
ment of Sgo1 and Aurora B to the centromere (Kitajima et al., 
2004, 2005; Tang et al., 2004b; Vaur et al., 2005; Fernius and 
Hardwick, 2007; Perera et al., 2007; Yamagishi et al., 2010; 
Kawashima et al., 2010; Wang et al., 2011).
The function of the essential checkpoint kinases Bub1 and BubR1 requires their recruitment to mitotic kinetochores. Kinetochore recruitment of Bub1 and 
BubR1 is proposed to rely on the interaction of the tetra­
tricopeptide repeats (TPRs) of Bub1 and BubR1 with two 
KI motifs in the outer kinetochore protein Knl1. We deter­
mined the crystal structure of the Bub1 TPRs in complex 
with the cognate Knl1 KI motif and compared it with the 
structure of the equivalent BubR1TPR–KI motif complex. 
The interaction developed along the convex surface of 
the TPR assembly. Point mutations on this surface impaired 
the interaction of Bub1 and BubR1 with Knl1 in vitro and 
in vivo but did not cause significant displacement of Bub1 
and BubR1 from kinetochores. Conversely, a 62­residue 
segment of Bub1 that includes a binding domain for the 
checkpoint protein Bub3 and is C terminal to the TPRs was 
necessary and largely sufficient for kinetochore recruit­
ment of Bub1. These results shed light on the determinants 
of kinetochore recruitment of Bub1.
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assembly of three complexes, the Knl1 complex (KNL1­C, 
comprised of Knl1 and Zwint­1), the MIS12 complex (MIS12­C, 
comprised of Mis12/Mtw1, Dsn1, Nnf1, and Nsl1), and the 
NDC80 complex (NDC80­C, comprised of Ndc80/Hec1, Nuf2, 
Spc24, and Spc25). The KMN network mediates microtubule 
attachment through microtubule­binding domains located in 
the Ndc80 and Knl1 subunits (Cheeseman and Desai, 2008; 
Santaguida and Musacchio, 2009). It has also been implicated 
in the recruitment of all known checkpoint proteins, suggesting 
that it plays a crucial role in relaying microtubule attachment 
status to the spindle checkpoint response.
The TPRs of Bub1 and BubR1 interact with distinct, but 
related, 12­residue motifs in the N­terminal region of Knl1, the 
KI motifs (from the first two residues of their consensus se­
quence, KI(D/N)XXXF(L/I)XXLK, in which X’s are noncon­
served residues; Fig. 1 A; Bolanos­Garcia et al., 2011; Kiyomitsu 
et al., 2011). The two consecutive motifs are herewith indicated 
as KI1 and KI2. Although it was originally hypothesized that 
these interactions might engage residues on the concave surface 
of the superhelically twisted TPR repeat assemblies of Bub1 
and BubR1 (D’Arcy et al., 2010; Kiyomitsu et al., 2011), a very 
recent structural analysis of the BubR1–KI2 complex revealed 
that the KI2 motif of Knl1 engages the convex surface of the 
BubR1 TPR region (Bolanos­Garcia et al., 2011).
The potential importance of the interaction of the KI 
motif of Knl1 with the Bub1 TPRs is underpinned by the ob­
servation that a point mutant in the TPRs prevents kinetochore 
recruitment of Bub1 (Kiyomitsu et al., 2007). Furthermore, 
depletion of Knl1 by RNAi prevents kinetochore recruit­
ment of Bub1 and BubR1 (Kiyomitsu et al., 2007). Finally, a 
deletion mutant lacking the TPRs of Bub1 failed to localize 
to kinetochores, reinvigorating the previously dismissed idea 
that this region of Bub1 participates in kinetochore recruit­
ment (Klebig et al., 2009). Thus, both the N­terminal TPRs 
and the Bub3­BD, which bind to Knl1 and Bub3, are thought 
to contribute to kinetochore recruitment of Bub1 and BubR1, 
but there is no unifying view of the relative importance of their 
contributions. We have therefore set out to clarify this impor­
tant question.
Results
Role of the TPRs of Bub1 and BubR1  
in kinetochore recruitment
We tested whether the TPR domain of human Bub1 (included in 
two constructs encompassing residues 1–150 or residues 1–190) 
is sufficient for kinetochore binding in HeLa cells. Expression 
of EGFP fusions of wild­type full­length Bub1 (Bub1(FL)) re­
sulted in bright kinetochore staining (Fig. 1 B and Fig. S1 for 
expression levels of the transgenes). On the other hand, EGFP 
fusions of Bub1(1–150) or Bub1(1–190) failed to localize to 
kinetochores (Fig. 1 B). These results suggest that the TPR region 
of Bub1 is not sufficient for kinetochore localization. We next 
tested whether this region is necessary for kinetochore bind­
ing. Bub1 mutants lacking either 150 or 189 residues from their 
N terminus (Bub1(150) or Bub1(189)) localized normally 
to kinetochores (Fig. 1 B). It is unlikely that these results were 
BubR1, whose overall domain organization is very simi­
lar to that of Bub1 (Fig. 1 A), is also implicated both in the 
spindle checkpoint and in chromosome alignment (Li and 
Murray, 1991; Taylor et al., 1998; Chan et al., 1999; Johnson 
et al., 2004; Lampson and Kapoor, 2005). Unlike Bub1, BubR1 
is incorporated together with Bub3, Mad2, and Cdc20 in the 
checkpoint effector, the so­called mitotic checkpoint complex, 
which inactivates the anaphase­promoting complex/cyclosome 
to prevent mitotic exit (Musacchio and Salmon, 2007).
Kinetochore recruitment of Bub1 and BubR1 may be 
strongly intertwined with their activation and functions there. 
For instance, kinetochore localization of Bub1 and BubR1 
might be important for their phosphorylation, which in turn 
contributes to the functions of these kinases (Yamaguchi et al., 
2003; Elowe et al., 2010). The exact mechanism of kinetochore 
recruitment of Bub1 and BubR1, however, remains unclear. It 
was originally shown that 300 residues in the N­terminal re­
gion of murine Bub1 (shown schematically in Fig. 1 A) are suf­
ficient for kinetochore localization (Taylor and McKeon, 1997; 
Taylor et al., 1998). This region of Bub1 includes an array 
of three tetratricopeptide repeats (TPRs; D’Arcy et al., 2010; 
Bolanos­Garcia et al., 2011, 2009) followed by a motif, also 
present in BubR1, which binds to the checkpoint protein Bub3 
(Taylor et al., 1998). Bub3 is a ­propeller structure that uses 
its top surface to interact directly with the Bub3­binding motifs 
of Bub1 and BubR1/Mad3 (Larsen et al., 2007). The Bub3­
binding motif is now also often referred to as the Gle2 binding 
site (GLEBS) motif (Wang et al., 2001). Here, however, we 
prefer to use the name Bub3­binding domain (abbreviated as 
Bub3­BD) because there is no evidence, to our knowledge, that 
Bub1 and BubR1 interact with the Gle2 protein (also known 
as Rae1).
Further deletion mapping of Bub1 demonstrated that the 
TPR region is dispensable for kinetochore localization and that 
a segment containing the Bub3­BD might be sufficient for 
kinetochore localization (Taylor et al., 1998). Mutations in the 
Bub3­BD prevent kinetochore localization of Bub1 and BubR1 
and impair BubR1’s function in checkpoint and chromosome 
congression (Taylor et al., 1998; Klebig et al., 2009; Malureanu 
et al., 2009; Elowe et al., 2010). As the only known function of 
the Bub3­BD of Bub1 and BubR1 is Bub3 binding, these data 
argue that the interaction of Bub1 and BubR1 with Bub3 might 
be necessary and sufficient for their kinetochore localization. 
Partly contradicting this idea, however, depletion of Bub3 does 
not affect Bub1 localization, whereas it might affect the local­
ization of BubR1 (Meraldi et al., 2004; Logarinho et al., 2008). 
Conversely, depletion of Bub1 or BubR1 was found to reduce 
kinetochore recruitment of Bub3, suggesting that these proteins 
are not simply recruited by Bub3 (Sharp­Baker and Chen, 2001; 
Chen, 2002).
More recently, insight into the mechanism of kinetochore 
recruitment of Bub1 and BubR1 developed around the discovery 
that their TPRs interact with the outer kinetochore protein Knl1 
(also known as Blinkin, CASC5, and AF15q14 in human cells, 
Spc105 in Saccharomyces cerevisiae, and Spc7 in Schizosac-
charomyces pombe; Kiyomitsu et al., 2007, 2011; Schittenhelm 
et al., 2009). Knl1 is a subunit of the KMN network, a 10­subunit 
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Overall, these results indicate that the TPR region of Bub1 and 
BubR1 is neither sufficient, nor strictly necessary, for kineto­
chore recruitment.
The TPR domains of Bub1 and BubR1  
bind Knl1 directly
The TPR regions of Bub1 and BubR1 have been previously 
shown to mediate an interaction with the kinetochore protein Knl1 
and have been suggested to promote the recruitment of Bub1 
and BubR1 to kinetochores via this interaction (Kiyomitsu 
et al., 2007, 2011; Klebig et al., 2009; D’Arcy et al., 2010). Our 
results in Fig. 1, however, indicate that the TPR region of 
Bub1 is neither sufficient nor necessary for kinetochore re­
cruitment. To reconcile these apparently contradictory obser­
vations, we hypothesized a more complex recruitment model. 
We speculated that an intramolecular interaction involving 
the N­terminal TPR motif might be masking a high­affinity, 
an artifact from fusing EGFP at the N terminus of the Bub1 
deletion constructs because a C­terminal fusion of Bub1(189) 
also localized normally to kinetochores (Fig. S1, E and F). When 
we created longer deletions and removed the first 436 residues 
(Bub1(436)), the resulting Bub1 construct failed to localize 
to kinetochores (Fig. 1 B). These results suggest that residues 
190–436, from which the TPR repeats of Bub1 are excluded, 
might be necessary for kinetochore recruitment of Bub1.
We next tested whether the TPR domain of BubR1 is im­
portant for kinetochore recruitment. Two constructs encom­
passing residues 1–204 and 1–328, which include the TPR 
region (Fig. 1 A), were expressed in HeLa cells and found to 
be unable to reach kinetochores (Fig. 1 C and Fig. S1 C for ex­
pression levels of the transgenes). Analogously to the results 
obtained with Bub1 deletion mutants, deletion of the TPR do­
main of BubR1 (BubR1(204) or BubR1(328)) did not evi­
dently affect kinetochore recruitment (Fig. 1 C and Fig. S1 D). 
Figure 1. TPRs are not sufficient or necessary for 
kinetochore recruitment of Bub1 and BubR1. (A) Sche-
matic view of the domain structure of Bub1, BubR1, 
and Knl1; TPR, tetratricopeptide repeats; Bub3-BD, 
Bub3-binding domain, also known as GLEBS motif; 
KEN, KEN box; PP1-BD, protein phosphatase 1–
binding domain; KI1, Bub1-binding domain 1; KI2, 
BubR1-binding domain 2; Mis12-BD, Mis12-binding 
domain; N, N terminus. (B and C) Immunofluores-
cence images of mitotic cells expressing different 
Bub1 (B) and BubR1 (C) constructs. HeLa cells were 
transiently transfected with plasmids containing 
EGFP alone, N-terminally EGFP-tagged Bub1, or BubR1 
constructs. Cells were treated with nocodazole, pro-
cessed for immunofluorescence, and stained with 
DAPI (DNA) and CREST (calcinosis, Raynaud’s phe-
nomenon, esophageal dysmotility, sclerodactyly, 
and telangiectasia) sera (kinetochores). Insets show a 
higher magnification of kinetochore regions (boxes). 
Bars, 5 µm. All images were acquired within the 
same experiment.
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the TPR region is predicted not only to remove the Knl1 binding 
site but also to relieve an intramolecular inhibitory function, 
with the consequent constitutive exposure of the high­affinity 
binding site even in the absence of Knl1 binding.
secondary kinetochore­binding domain in Bub1 and BubR1. 
This secondary site would provide the bulk of the kinetochore­
binding affinity but should only become exposed after the initial 
binding of Knl1 to the TPR motifs. In such a model, deletion of 
Figure 2. Direct binding of Bub1 and BubR1 TPRs 
to Knl1 KI motifs. (A) The interaction of Bub1(1–
150) with Knl1(150–250) was analyzed by size-
exclusion chromatography, which separates based 
on size and shape. (B) Analysis of the interaction of 
BubR1(1–204) with Knl1(150–250). (C) Analysis 
of the interaction of Bub1(1–150) with Knl1(150–
200) or Knl1(201–250). (D) Analysis of the inter-
action of BubR1(1–204) with Knl1(150–200) or 
Knl1(201–250). M, molecular mass marker; L, 
sample loaded on the column. The same elution 
profile for Knl1(150–250) was used as a control 
for A and B. Molecular markers are given in kilo-
daltons. mAu, milliabsorbance unit.
 o
n
 June 18, 2012
jcb.rupress.org
D
ow
nloaded from
 
Published February 13, 2012
455Characterization of the Bub1–Knl1 interaction • Krenn et al.
density. Thus, the structure is in agreement with the idea 
that the Bub1 binding site on Knl1 is essentially limited to the 
previously identified KI motif (Kiyomitsu et al., 2011). The dis­
sociation constant (Kd) for the interaction of Bub1(1–150) with a 
fluorescent synthetic peptide corresponding to Knl1 residues 
174–190, measured by fluorescence polarization anisotropy, 
was 35 µM (Fig. 4 B). In the structure, most of the KI 
motif folds as a short  helix that lies on the convex sur­
face of Bub1. Several Knl1 residues, including Ile177, Thr179, 
and Phe182, point toward the Bub1 surface. These residues 
make extensive van der Waals contacts with the Bub1 surface 
(Fig. 4 A). Additionally, there are hydrogen bonds between 
Thr179(Knl1) and Thr180(Knl1) with Gln84(Bub1). These 
observations are consistent with a previous analysis of the 
effects of mutations in the KI1 motif of Knl1 on Bub1 bind­
ing (Kiyomitsu et al., 2011). On Bub1, the A­type helix 4 
contributes the side chains of Phe75 and Asn79, thus participat­
ing from the bottom to the creation of the Knl1­binding ridge. 
The B­type 3 and 5 helices surround the ridge, with 5 con­
tributing the side chains of Gln84, Phe85, and Phe88 (Fig. 4 A).
In vitro and in vivo validation of the  
Bub1–Knl1 interaction
We individually mutated Phe75, Asn79, Gln84, and Phe85 
to alanine and evaluated the ability of the mutants to bind 
Knl1(150–250) by size­exclusion chromatography (mutation 
of Phe88 to alanine rendered the protein insoluble when ex­
pressed in Escherichia coli; Fig. 4 C). We observed essentially 
complete disruption of the Bub1(1–150)–Knl1(150–250) com­
plex in three out of four cases (only the Gln84 to Ala mutant 
had mild or no effects on binding). The results confirm the 
role of the interface on the convex surface of Bub1 in Knl1 
binding in vitro.
Next, we tested the effects of Bub1 mutations on the abil­
ity of Bub1 to bind Knl1 in vivo. For this, we generated stable 
inducible cell lines expressing EGFP­tagged wild­type Bub1 
and a mutant carrying the four alanine mutations characterized 
in Fig. 4 C (Bub1(4A)). We next evaluated the interaction of 
An implication of the model is that if one were able to 
selectively perturb the interaction of Bub1 with Knl1, without 
disrupting the hypothetical intramolecular switch, the result­
ing mutant impaired in Knl1 binding might also be impaired 
in kinetochore binding as a consequence of constitutive inhi­
bition. Testing this model required a better understanding of 
the structural basis of the interaction of the Bub1 and BubR1 
TPRs with Knl1, so as to allow the creation of separation of 
function mutants. Thus, we attempted to unveil the biochemical 
and structural basis of this interaction. Because it is formally 
undemonstrated that the interaction of Bub1 and BubR1 with 
Knl1 is direct, we expressed and purified recombinant versions 
of Bub1(1–150) and BubR1(1–204) and tested their ability to 
bind to Knl1 constructs encompassing the previously identified 
KI motifs (depicted in Fig. 1 A; Kiyomitsu et al., 2011). When 
analyzed by size­exclusion chromatography (a technique that 
allows the separation of macromolecules based on their size and 
shape), Bub1(1–150) and BubR1(1–204) were shown to form 
stoichiometric complexes with Knl1(150–250), a construct that 
encompasses both the KI1 and the KI2 motif (Fig. 2, A and B). 
Conversely, Bub1(1–150) bound to Knl1(150–200), which con­
tains the KI1 motif (Fig. 2 C), but was unable to bind to Knl1 
(201–250), which contains the KI2 motif. Precisely the opposite 
result was obtained with BubR1(1–204). The latter bound Knl1 
(201–250), which contains the KI2 motif, but not Knl1(150–200), 
which contains the KI1 motif (Fig. 2 D). Thus, the TPR motifs 
of Bub1 and BubR1 bind directly and specifically to the KI1 and 
KI2 motif, respectively.
Crystal structure of the Bub1(1–150)–
Knl1(150–200) complex
Next, we determined the crystal structure of the Bub1(1–150)–
Knl1(150–200) complex. Single crystals of the complex dif­
fracted to a maximal resolution of 2.6 Å in the space group P21 
(Table 1). The four Bub1(1–150)–Knl1(150–200) complexes in 
the asymmetric unit are very similar, with the only exceptions 
occurring at intersubunit contacts. The description that follows 
refers to the general features of the complexes.
TPR repeats form helical hairpins, i.e., arrangements of 
two antiparallel  helices, denoted A and B. Subsequent repeats 
pack against each other, usually forming arrays of 3–16 repeats 
that are characterized by a right­handed superhelical twist that 
generates concave and convex surfaces. There are three TPR 
repeats in Bub1(1–150) (comprising helices 2–7), capped by 
N­terminal and C­terminal helices (1 and 8, respectively; 
Fig. 3 A). TPRs or equivalent arrangements of helical hairpins, 
such as HEAT repeats, usually bind their substrates on the con­
cave surface, a cradle for elongated protein ligands. In the case 
of Bub1(1–150)–Knl1(150–200), however, the Knl1 sequence 
binds to a moderately conserved ridge on the convex surface of 
Bub1 (Fig. 3, A and B). Secondary structure and level of conser­
vation are depicted in Fig. 3 C. On the concave surface, there is a 
distinct ridge that might provide a binding site for another sub­
strate or for an intramolecular interaction.
There is interpretable electron density for residues 175–189 
of Knl1, whereas the rest of the polypeptide chain is presum­
ably disordered in solvent and therefore invisible in the electron 
Table 1. Data collection used in this paper
Variable Value
Beamline ESRF ID14 EH1
a (Å) 59.3
b (Å) 131
c (Å) 75
 and  (°) 90
 (°) 110.2
Space group P21
Wavelength (Å) 0.9334
Resolution 65-2.6 (2.74-2.60)
Completeness (%) 98.8 (99.6)
Multiplicity 2.8 (2.8)
Mean (I)/(I) 13.7 (3.2)
Rmeas 0.072 (0.50)
Numbers in parentheses correspond to the highest resolution shell. Rmeas is the 
multiplicity-weighted merging R factor according to Diederichs and Karplus 
(1997). I, reflection intensity.
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By fluorescence polarization anisotropy, we determined that 
the binding affinity of BubR1(1–204) for a synthetic fluorescent 
peptide corresponding to Knl1(210–226) is 0.45 µM, almost 
100­fold tighter than the value measured for the interaction of 
Bub1(1–150) to Knl1(174–190) (Fig. 4 B and Fig. 5 C). The 
significance of this difference in binding affinity is currently 
unclear but might be caused by a technical limitation of the 
assay, as we note that Bub1(1–150) interacts stoichiometrically 
with Knl1(150–250) or Knl1 (150–200) when the individual 
proteins are mixed at a concentration of 5 µM, suggesting that 
the Kd of the interaction may realistically be lower (i.e., higher 
affinity. See Materials and methods for details on the assay).
While this paper was under review, the crystal structure 
of the complex of human BubR1 TPR region bound to the 
KI2 motif was published (Protein Data Bank accession no. 
3SI5; Bolanos­Garcia et al., 2011). The BubR1 backbone super­
imposes on the Bub1 TPR structure with a root­mean­square 
these constructs with endogenous Knl1, Hec1, and Mis12 by 
GFP immunoprecipitation followed by Western blotting. The 
Bub1(4A) mutant was severely impaired in its ability to inter­
act with Knl1, and only modest residual binding was retained 
(Fig. 4 D). Because Knl1 interacts directly with other compo­
nents of the KMN network, including subunits of the Mis12 
and Ndc80 complexes (Cheeseman et al., 2006; Petrovic et al., 
2010), the levels of Mis12 and Ndc80 were also reduced. Anal­
ogous results were obtained with the Bub1(189) deletion mu­
tant (Fig. 4 D). These results strongly support the view, based 
on the crystal structure, that the convex surface of the Bub1 
TPR region contributes to Knl1 binding in cells.
Interaction of BubR1 with Knl1
The sequences of the TPR regions of Bub1 and BubR1 are 
closely related (Fig. 5 A). Similarly, the sequences of the previously 
identified KI motifs of Knl1 are also closely related (Fig. 5 B). 
Figure 3. Crystal structure of the Bub1(1–150)–Knl1(150–200) complex. (A) Side and top view of a cartoon representation of Bub1(1–150) (gray) and 
Knl1 peptide (red). (B) Surface representation of the complex, oriented so as to show the convex (left) and concave (right) side. Sequence conservation 
(limited to Bub1 orthologues) was mapped onto the Bub1 structure using ConSurf (Ashkenazy et al., 2010). The structure was illustrated using PyMOL 
(Delano Scientific, LLC). (C) Sequence of the Bub1 (gray) and Knl1 (red) fragments used for crystallization. Secondary structure elements are mapped onto 
the sequence. C, C terminus; N, N terminus.
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the binding interface of BubR1 and appears to make favor­
able contacts that are likely to contribute significantly to the 
interaction (Fig. S2). In KI1, Thr179 substitutes for Phe215 
of KI2. Its smaller side chain contributes more modestly to 
the binding interface.
Residues Trp125, Leu128, Cys132, Asp137, and Met138 
of BubR1 occupy positions that are equivalent to those identi­
fied at the Bub1–Knl1 interface (Fig. 5, A [alignment] and E) 
and which have been recently shown to participate in the inter­
action with the KI2 region (Bolanos­Garcia et al., 2011). To 
probe the function of these residues in Knl1 binding, we mutated 
them individually into alanine and used size­exclusion chroma­
tography to probe the interaction with Knl1(150–250) (Fig. 5 F). 
Individual mutations of Trp125, Leu128, Cys132, or Asp137 
deviation of 1.41 Å over 129 atoms. The interactions of the 
KI2 motif with BubR1 and of the KI1 motif with Bub1 en­
gage equivalent interfaces located between helices 3 and 
5 of the TPR assembly. Furthermore, like KI1, KI2 also 
adopts a helical conformation in complex with the BubR1 
TPR (Fig. 5 D). Thus, there are extensive structural similarities 
between these two interactions (further analyzed in Fig. S2). 
Nevertheless, two features of the interaction of KI2 with 
BubR1 might explain its specificity and its apparently higher 
affinity with respect to the KI1–Bub1 complex. First, Arg221 
of KI2 is perfectly positioned to interact with the side chains 
of Glu103 and Glu107 of BubR1. Asn185 of KI1, equivalent 
to Arg221 of KI2, does not form equally favorable contacts. 
Second, the bulky side chain of Phe215 of KI2 points toward 
Figure 4. Validation of the Bub1(1–150)–Knl1(150–200) binding mechanism. (A) Close-up of the interaction of the Knl1–Bub1 interaction (red and gray, 
respectively). (B) Fluorescence polarization anisotropy experiments for the interaction of a fluorescent version of Knl1(174–190) with Bub1(1–150). Red 
line is a fit of the data with the equation discussed in Materials and methods, Fluorescence anisotropy. AU, absorbance units. (C) Elution profiles for size-
exclusion chromatography runs for binding reactions of the indicated Bub1(1–150) mutants with Knl1(150–250). The elution profile for the interaction 
of wild-type Bub1(1–150) with Knl1(150–250) is shown in red. The same control profile is shown in all graphs, with its height scaled to the height of the 
profile of mutant. (D) Immunoprecipitation of EGFP-tagged Bub1(WT), Bub1(4A), and Bub1(189). Bub1(4A) contains the F75A, N79A, Q84A, and 
F85A mutations. Mitotic extracts from stable inducible cell lines expressing various EGFP-fused Bub1 proteins were immunoprecipitated by GFP-Traps. 
Coimmunoprecipitating proteins were analyzed by SDS-PAGE and subsequent Western blotting. Ponceau is used as a loading control. WT, wild type; 
Mm, molecular mass; IP, immunoprecipitation.
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buried (Bolanos­Garcia et al., 2011). Overall, these results 
demonstrate that BubR1 interacts with its cognate KI2 motif of 
Knl1 using a surface on the TPR that is analogous to that used 
by Bub1 to bind KI1.
to alanine were sufficient to disrupt the interaction with 
Knl1(150–250), whereas the effect of mutating Met138 was 
milder. Furthermore, structural analysis of the BubR1–KI2 
complex shows that the side chain of this residue is partly 
Figure 5. Modeling and validation of the BubR1–Knl1 binding mechanism. (A) Sequence alignment of the human Bub1 and BubR1 TPRs; residues high-
lighted in yellow occupy similar positions at the Knl1 interface and were mutated as discussed in the section Interaction of BubR1 with Knl1. (B) Alignment 
of the KI motifs of human Knl1; residues highlighted in red define the conserved binding motifs KI1 and KI2. (C) Fluorescence polarization anisotropy 
experiments for the interaction of a fluorescent version of Knl1(210–226) with BubR1(1–204). Red line is a fit of the data with the equation discussed in 
Materials and methods, Fluorescence anisotropy. AU, absorbance units. (D) The structure of the BubR1 TPRs bound to the KI2 region of Knl1 (gray and 
red, respectively; Protein Data Bank [PDB] accession no. 3SI5; Bolanos-Garcia et al., 2011) is displayed in the same orientation used in Fig. 3 A. The KI2 
peptide is positioned on BubR1 on an interface between helices 3 and 5, like the KI1 peptide on Bub1. (E) Close-up of the structure in D from a slightly 
rotated view emphasizing the role of BubR1 residues implicated in Knl1 binding. (F) Elution profiles for size-exclusion chromatography runs for binding 
reactions of the indicated BubR1(1–204) mutants with Knl1(150–250). C, C terminus; N, N terminus.
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the context of the full­length protein, i.e., without resorting 
to deletion mutants that might disrupt hypothetical intra­
molecular regulatory steps. We therefore tested the ability of 
EGFP fusions of Bub1 or BubR1 mutants carrying multiple 
alanine substitutions on their KI1 or KI2 binding sites, re­
spectively (described in the legend of Fig. 6 and abbreviated 
as Bub1(3A), Bub1(4A), BubR1(4A), and BubR1(4A)*) or of 
individual alanine point mutants (Fig. S3, A and B) to be re­
cruited to kinetochores.
We thus generated stable doxycycline­inducible HeLa 
cell lines. After a 24­h treatment with doxycycline, EGFP­tagged 
proteins were expressed at comparable levels that equaled or 
slightly exceeded the levels of endogenous Bub1 or BubR1 
(Fig. 6 A). As for the case of the N­terminal deletion mutants, 
Knl1 binding and kinetochore recruitment 
of Bub1 and BubR1
Results in Fig. 1 demonstrate that the N­terminal TPR regions 
of Bub1 and BubR1 are not sufficient for kinetochore recruit­
ment. More surprisingly, the results also suggest that these 
regions might not even be strictly necessary for kinetochore 
recruitment. A possible conclusion from this analysis is that 
the interaction of the Bub1 and BubR1 TPR with the Knl1 
(150–250) region might not be essential for kinetochore re­
cruitment of these checkpoint kinases.
As explained in section The TPR domains of Bub1 and 
BubR1 bind Knl1 directly, the characterization of Knl1­binding 
interfaces on Bub1 and BubR1 allowed us to probe the role of 
Knl1 binding in kinetochore recruitment of these proteins in 
Figure 6. Bub1 mutants impaired in Knl1 binding are recruited to kinetochores. (A) Western blots of extracts from Flp-In T-REx cell lines expressing EGFP-
tagged Bub1 (top) and BubR1 (bottom) wild type (WT) or carrying mutations in the TPR, in the absence or presence of doxycycline (DOX). Bub1(4A) and 
Bub1(3A) contain the F75A, N79A, Q84A, and F85A mutations and N79A, F85A, and F88A, respectively. BubR1(4A) and BubR1(4A*) contain the 
W125A, L128A, C132A, and D137A and W125A, L128A, C132A, and M138A mutations, respectively. End, endogenous. (B and C) Immunofluor-
escence of Bub1 (B) and BubR1 (C) cells treated with doxycyclin and nocodazole. Cells were stained with DAPI (DNA) and CREST sera (kinetochores). 
Insets show a higher magnification of kinetochore regions (boxes). Bars, 5 µm. (D) Graphs showing the mean GFP intensity of kinetochores in cells used in 
B (left) and C (right) normalized to the mean GFP intensity of wild-type signals. n indicates the numbers of measured kinetochores. Error bars indicate SEM. 
a.u. arbitrary unit; MM, molecular mass.
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contrary, the data strongly suggest that the TPR regions of 
Bub1 and BubR1 play a marginal role in kinetochore recruit­
ment of Bub1 and BubR1.
Effects of the TPR region on the kinase 
activity of Bub1
To investigate alternative functions of the TPR region, we asked 
whether it influenced the catalytic activity of Bub1. Various 
EGFP­Bub1 constructs were expressed in stable doxycycline­
inducible HeLa cell lines, partially purified via EGFP immuno­
precipitation, and tested in kinase assays with H2A as a substrate. 
To assess the specificity of Bub1 activity in our immunopre­
cipitates, we first confirmed that the activity of a recombinant 
version of Bub1–Bub3 purified from insect cells was inhibited 
with 5 µM 2OH­BNPP1, a small­molecule inhibitor of Bub1 
(Fig. S4 A; Kang et al., 2008). Next, we added 2OH­BNPP1 
to a kinase assay reaction with immunoprecipitated Bub1 and 
found levels of inhibition comparable with those observed with 
the recombinant kinase (Fig. S4 B). These experiments testify 
to the specificity of the kinase assay. As an additional control, 
we tested the effects of mutations in the active site of the recom­
binant Bub1–Bub3 kinase (Fig. S4 C).
Next, we tested the H2A kinase activity of immuno­
precipitates of cycling cells expressing similar amounts of EGFP­
Bub1 or its variants, including Bub1(4A), Bub1(189), and a 
kinase­dead mutant (Bub1(KD); Fig. S4 D). Deletion of the 
TPR region decreased the kinase activity of Bub1 to levels 
comparable with those of the kinase­dead mutant (Fig. 7 A). 
On the other hand, the catalytic activity of Bub1(4A) was un­
affected in this assay, suggesting that the ability of this domain 
to bind Knl1 might not be essential for Bub1 kinase activity 
and that the determinants required for activity map elsewhere 
in the TPR region. Essentially identical results were obtained 
when using H3 (histone 3) as a substrate (unpublished data). In 
agreement with the idea that the interaction with Knl1 does not 
modulate the catalytic activity of the Bub1–Bub3 complex, the 
H3 kinase activity of recombinant Bub1–Bub3 purified from 
insect cells was not affected by the addition of a recombinant 
Knl1(150–200) segment (Fig. 7 B).
Identification of the minimal kinetochore-
binding domain of Bub1
We tried to identify a minimal kinetochore­binding domain of 
Bub1. In Fig. 1, we demonstrated that residues 190–436, from 
which the TPRs of Bub1 are excluded, might be necessary for 
kinetochore recruitment of Bub1. To test whether this region is 
also sufficient for kinetochore recruitment, we generated a con­
struct encompassing Bub1 residues 190–447. In agreement with 
the idea that this region of Bub1 is sufficient for kinetochore 
localization, EGFP­Bub1(190–447) localized normally at the 
kinetochore (Fig. S5 A). Although Bub1(1–150) failed to local­
ize at kinetochores, inclusion of a C­terminal segment that 
included the Bub3­BD of Bub1 (Bub1(1–284)) led to robust ki­
netochore recruitment (Fig. S5 A). These results indicate that a 
segment comprised between residues 190 and 284 of human 
Bub1 is sufficient for kinetochore recruitment, in agreement 
with a previous study (Taylor et al., 1998).
kinetochore recruitment of Bub1(3A) or Bub1(4A) was not 
affected; recruitment of the two variants of BubR1(4A) was 
increased relative to the wild­type control (Fig. 6, B–D). As a 
further control, and to exclude any possible effect from endog­
enous Bub1, we assessed kinetochore recruitment of EGFP­
Bub1 proteins in HeLa cells in which we had previously 
depleted Bub1 by RNAi (Fig. S3, C–E). Also in this case, we 
observed normal kinetochore recruitment of Bub1(4A) and 
Bub1(189). Overall, these observations confute the hypothe­
sis that the interaction of the TPR regions of Bub1 and BubR1 
with the KI motifs of Knl1 regulates intra­ or intermolecu­
larly the degree of exposure of a kinetochore­binding region 
located elsewhere in the sequence of Bub1 or BubR1. On the 
Figure 7. Deletion of the TPR region represses Bub1 kinase activity. (A) In vitro 
kinase activity of anti-EGFP immunoprecipitates of EGFP and the indicated 
EGFP-fused Bub1 proteins from Flp-In T-REx cell lines. Kinase activity was 
tested on histone 2A (H2A) as a substrate; KD, kinase dead, carrying 
K821R mutation; AR, autoradiography; CB, Coomassie brilliant blue; a.u., 
arbitrary unit. The quantification data shown are from a single representa-
tive experiment out of two repeats. (B) A time course of H3 phosphorylation 
in the presence of the recombinant Bub1–Bub3 complex, in the absence 
(left) or in the presence (right) of Knl1(150–200). IB, immunoblot; Mm, 
molecular mass; WT, wild type.
 o
n
 June 18, 2012
jcb.rupress.org
D
ow
nloaded from
 
Published February 13, 2012
461Characterization of the Bub1–Knl1 interaction • Krenn et al.
Next, we refined our analysis of this interaction by ex­
pressing additional constructs, including Bub1(209–270) and 
Bub1(227–270). The latter construct matched almost exactly 
the segment of budding yeast Bub1 that was previously cocrys­
tallized with Bub3 (Larsen et al., 2007), whereas the former is 
preceded by an 18­residue N­terminal extension of unknown 
function (Fig. 8 A, alignment). Although Bub1(209–270) local­
ized robustly to kinetochores, Bub1(227–270) was unable to 
reach kinetochores (Fig. 8 B and Fig. S5 B for expression lev­
els). These results suggest that efficient kinetochore recruitment 
requires the Bub3­BD and a short N­terminal extension.
To test the importance of the Bub3­binding region, we 
mutated Glu248 of Bub1, a residue previously shown to be essen­
tial for the interaction of Bub1 with Bub3 (Larsen et al., 2007), 
into lysine (E248K, referred to as EK mutant) in the context 
of the Bub1(209–270) construct and expressed it in HeLa cells 
(Fig. S5 C shows expression levels). As expected, the mutation 
abolished kinetochore recruitment of the Bub1(209–270) con­
struct, demonstrating that binding to Bub3 is essential for ki­
netochore localization of Bub1 (Fig. 8 C). Moreover, the E248K 
mutation did not have additional effects on kinetochore locali­
zation in the context of Bub1 (227–270) (Fig. S5, D and E).
To assess whether the N­terminal segment of the Bub1 
(209–270) construct shown to be necessary for kinetochore 
recruitment is also important for the interaction with Bub3, 
we expressed GFP fusion proteins of Bub1(209–270), Bub1 
(227–270), and Bub1(227–270­EK) in HeLa cells and quanti­
fied the abundance of Bub3 in the resulting anti­GFP immuno­
precipitates (Fig. 8 D). We observed a strong correlation between 
the strength of Bub3 binding by the different constructs and 
their interaction with kinetochores, in agreement with the 
results from localization experiments (Fig. 8 B and Fig. S5 D). 
This result supports the idea that Bub3 binding is essential 
for the interaction of Bub1 with kinetochores. This idea was 
further emphasized by robust coprecipitation of at least two 
kinetochore subunits, Knl1 and Hec1, with Bub1(209–270), 
a construct that binds Bub3 with high affinity (Fig. 8 D). 
Similarly, the interaction of Bub1 with BubR1 appeared to 
correlate with the ability of Bub1 to bind Bub3 (Fig. 8 D). 
Conversely, Bub1(227–270) and Bub1(227–270­EK), which 
bind poorly to Bub3, did not interact robustly with kineto­
chores or BubR1.
Discussion
Structural analysis of Bub1, a 1,085­residue multidomain pro­
tein, has so far revealed the organization of the kinase domain 
(Kang et al., 2008), the TPR region (Bolanos­Garcia et al., 
2009; D’Arcy et al., 2010), and of the Bub3­BD in complex 
with Bub3 (Larsen et al., 2007). Here, we extend these previous 
analyses by elucidating the structure of the complex of the Bub1 
TPRs with its cognate KI1 motif of Knl1. The Knl1­binding 
interface is located on the convex surface of the TPRs. Our 
structure is equivalent to the crystal structure of the BubR1 
TPRs bound to the KI2 region of Knl1, which was reported 
while this paper was under review (Bolanos­Garcia et al., 
2011). Based on current structural knowledge on the interaction 
of helical repeats with their protein ligands, this is unusual but 
not unprecedented. For instance, the S. cerevisiae protein Caf4 
interacts both on the concave and convex surface of the TPRs 
of Fis1 (Protein Data Bank accession no. 2PQR; Zhang and 
Chan, 2007).
It is plausible that the regulation of the catalytic output of 
Bub1 at kinetochores is mediated by complex intramolecular 
conformational changes triggered by kinetochores. Structural 
analysis of the kinase domain of Bub1, which revealed an 
intramolecular inhibitory switch that must be relieved for full 
kinase activation, lends support to this hypothesis (Kang et al., 
2008). Our observations show that the N­terminal region of 
Bub1 influences the catalytic output of the kinase domain at 
the opposite end of the primary structure but that this effect 
might not depend on the KI1­binding interface (Fig. 7 A). 
In the future, we will try to clarify whether this occurs by 
releasing the previously identified intramolecular inhibitory 
mechanism (Kang et al., 2008). Furthermore, we show that the 
interaction of Bub1 with Bub3, and therefore presumably with 
kinetochores, is important to mediate the interaction of Bub1 
with BubR1. Future studies will have to address the precise 
molecular mechanism through which these effects take place. 
Eventually, these studies will illuminate the detailed molecu­
lar mechanism of activation of Bub1, and possibly of BubR1, 
at the kinetochore.
By showing that the Bub3­binding region of Bub1, rather 
than the TPRs, is essential for kinetochore recruitment, our 
analysis resolves an open controversy, and it lends support to 
original studies indicating that the Bub3­BD of Bub1 (Taylor 
et al., 1998), later renamed (less informatively) as GLEBS motif 
(Wang et al., 2001), is necessary and sufficient for kinetochore 
recruitment of Bub1. The previously described deleterious effects 
on kinetochore localization of the mutations Leu122 to Gly 
(L122G, already mentioned in the Introduction; Kiyomitsu et al., 
2007) might be an unexpected consequence of the destabiliza­
tion of the hydrophobic core of the TPR region, where the side 
chain of Leu122 is located.
Impairment of the interaction of the Bub1 TPRs with the 
KI motif is, in principle, expected to reduce the kinetochore­
binding affinity of Bub1. But the extent of this effect, if at all 
existing, is insufficient to alter the levels of kinetochore Bub1 
significantly. With the goal of identifying subtle differences 
in the dynamics of kinetochore residence of Bub1 or of the 
Bub1 mutants incapable of binding Knl1, we performed FRAP 
experiments. These experiments, however, failed to reveal signif­
icant differences in recovery rates between Bub1(WT) and the 
Bub1(4A) mutant impaired in Knl1 binding (unpublished data).
Our analysis of the requirements for recruiting BubR1 to 
kinetochores is also in line with previous studies showing that 
BubR1(1–203) or BubR1(1–363) is unable to reach kineto­
chores, whereas a BubR1(357–1,052) construct localizes ap­
parently normally (Malureanu et al., 2009; Elowe et al., 2010). 
When considered together, therefore, the available evidence 
supports the unifying theme that the TPR regions of Bub1 and 
BubR1 are both dispensable for kinetochore recruitment. At 
least in the case of Bub1, its Bub3­binding region, likely through 
concomitant interactions of Bub3 with currently unknown 
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Figure 8. Minimal kinetochore-binding domain and the role of the TPR region. (A) Sequence alignment of the Bub3-binding region of Bub1 (Hs, Homo 
sapiens; Xl, Xenopus laevis; Dr, Danio rerio; Sc, S. cerevisiae. (B) Fluorescence images of mitotic HeLa cells expressing the indicated EGFP-Bub1 constructs 
and treated with nocodazole. Cells were stained with DAPI (DNA) and CREST sera (kinetochores). Insets show a higher magnification of kinetochore 
regions (boxes). (C) Immunofluorescence images of mitotic HeLa cells expressing the EGFP-tagged fragments of the Bub3-BD of Bub1 and carrying the 
E248K mutation (EK). Cells were treated as in B. Note that the E248K mutation abolished the localization of EGFP-Bub1(209–270). The data in B and C 
derive from a single experiment, and the same image for the Bub1(209–270) construct is shown in B and C. (D) Immunoprecipitation of EGFP-tagged Bub1 
proteins. HeLa cells were transfected with the corresponding plasmids and treated with 330 nM nocodazole for 16 h. (top) Coimmunoprecipitating proteins 
were analyzed by SDS-PAGE and Western blotting. On the bottom, a graph showing the quantification of Bub3 levels at the top normalized to the corre-
sponding GFP levels and normalized to the value of Bub1(209–270). The quantification data shown are from a single representative experiment out of two 
repeats. (E) Models of Bub1 and BubR1 kinetochore recruitment. Bub1 and BubR1 have similar domain structures, and it is plausible that they interact with 
kinetochores through partly related mechanisms. The interaction of Bubs with the Bub3-BD (yellow boxes) is crucial for kinetochore recruitment. The TPRs of 
Bub1 and BubR1 interact with the KI1 and KI2 motifs of Knl1, respectively. This interaction is important for the ability of Bub1 to bind BubR1 possibly be-
cause Knl1 acts as a scaffold for recruiting both proteins. The PP1-binding motif of Knl1 is negatively regulated through Aurora B phosphorylation. Aurora B, 
on the other hand, facilitates the interaction of Bub1 and BubR1 with kinetochores. N, N terminus; C, C terminus; WT, wild type. Bars, 5 µm.
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its kinetochore recruitment to the final phases of kinetochore–
microtubule attachment (Wu et al., 2009; Liu et al., 2010). 
Failure to recruit the PP1 phosphatase results in a metaphase 
arrest with an active spindle checkpoint (Maldonado and Kapoor, 
2011b; Rosenberg et al., 2011). In the future, it will be impor­
tant to investigate this complex network of interactions and 
if and how Bub1 recruitment to Knl1 impinges on the opposition 
of Aurora B and PP1.
Materials and methods
Mammalian plasmids
All the plasmids (except the one used in Fig. S1) were derived from 
the pcDNA5/FRT/TO vector (Invitrogen). The control plasmid for EGFP 
expression was created by PCR amplifying the EGFP sequence from 
pEGFP-C1 (Takara Bio Inc.) and cloning it into the pcDNA5/FRT/TO vector 
previously modified to carry an internal ribosomal entry site (IRES) se-
quence to obtain the pcDNA5/FRT/TO EGFP-IRES vector. To create all 
N-terminal EGFP-Bub1 plasmids, Bub1 sequences were obtained by PCR 
amplification from a pEGFP-C1 vector containing RNAi-resistant Bub1 
(a gift from M. Yanagida, University of Kyoto, Kyoto, Japan) and subcloned 
into the pcDNA5/FRT/TO EGFP-IRES vector. To create the BUB1(189)-
EGFP fusion used in Fig. S1, the Bub1 sequence was PCR amplified and 
cloned into pEGFP-N1 (Takara Bio Inc.). All Bub1 constructs were RNAi 
resistant (Kiyomitsu et al., 2007). To create all N-terminal EGFP fusions, 
BubR1 sequences were amplified by PCR and cloned in frame with the 
EGFP tag in the pcDNA5/FRT/TO EGFP-IRES vector. Site-directed muta-
genesis was performed with a mutagenesis kit (QuikChange; Agilent 
Technologies) to generate single and multiple mutants in the Bub1 and 
BubR1 constructs. pcDNA5/FRT/TO-based plasmids were used for both 
transient transfection and to generate stable inducible cell lines. All plas-
mids were checked by DNA sequencing.
Cell culture and transfection
HeLa cells were grown in DME (EuroClone) supplemented with 10% FBS 
(Hyclone) and 2 mM l-glutamine. Nocodazole (Sigma-Aldrich) was used at 
a concentration of 3.3 µM unless differently specified. 2 mM thymidine 
was purchased from Sigma-Aldrich. For all plasmid transfections of HeLa 
cells, transfection agent (FuGENE 6; Roche) was used at a 3:1 ratio with 
plasmid DNA. Cells were analyzed 36–68 h after transfection.
Flp-In T-REx HeLa cells used for stable doxycycline-inducible cell 
lines were a gift from S.S. Taylor (University of Manchester, Manches-
ter, England, UK). Flp-In T-REx HeLa host cell lines were maintained in 
DME with 10% tetracycline-free FBS (Invitrogen) supplemented with 50 µg/ml 
Zeocin (Invitrogen). Flp-In T-REx HeLa expression cell lines were gener-
ated as previously described (Screpanti et al., 2011). In brief, Flp-In 
T-REx HeLa host cells were cotransfected with a ratio of 9:1 (wt/wt) 
pOG44/pcDNA5/FRT/TO expression plasmid using transfection agent 
(FuGENE6). 48 h after transfection, Flp-In T-REx HeLa expression cell 
lines were put under selection for 2 wk in DME with 10% tetracycline-free 
FBS supplemented with 250 µg/ml hygromycin (Roche) and 5 µg/ml 
blasticidin (MP Biomedicals). The resulting foci were pooled and tested 
for expression. Gene expression was induced with 0.5 µg/ml doxycy-
cline (Sigma-Aldrich) for 24 h. To generate mitotic populations of these 
cells used in 4D, cells were treated with 330 nM nocodazole for 16 h. 
Mitotic cells were then harvested by shake off.
RNAi
Bub1 siRNA duplexes had the sequence 5-GGUUGCCAACACAAGU-
UCU-3 and were purchased from Thermo Fisher Scientific. To perform RNAi, 
50 nM Bub1 siRNA duplexes were transfected using Lipofectamine 2000 
reagent (Invitrogen) according to the manufacturer’s instructions. After 5 h 
from transfection of siRNA duplexes, cells were synchronized with a dou-
ble thymidine arrest. In brief, cells were washed with PBS, treated with 
thymidine for 16 h, and then released into fresh medium. 3 h after the 
release, 50 nM siRNA duplexes were transfected again. After 5 h from 
transfection of siRNA duplexes, cells were treated with thymidine for 16 h 
and released in fresh medium.
Immunoprecipitation and immunoblotting
Cells were lysed in lysis buffer (150 mM KCl, 75 mM Hepes, pH 7.5, 1.5 mM 
EGTA, 1.5 mM MgCl2, 10% glycerol, and 0.075% NP-40 supplemented 
targets, contributes the bulk of the binding affinity required for 
kinetochore binding (Fig. 8, B–D). A previous study making 
use of a 42­residue deletion in the Bub3­BD of BubR1 indicates 
that this might be true also for BubR1 (Taylor et al., 1998).
Identification of the kinetochore targets that mediate the 
interaction of Bub1 and BubR1 with kinetochores is of crucial 
importance. Knl1 is required for kinetochore recruitment of 
Bub1 and BubR1 (Kiyomitsu et al., 2007; Pagliuca et al., 2009). 
Because the interaction of Bub1 with the KI motifs of Knl1 is 
insufficient for kinetochore recruitment, it is plausible that at 
least another segment of Knl1 is involved, possibly through an 
interaction with the Bub3­binding region of Bub1 and with 
Bub3. This is in line with findings that Bub1 and Bub3 may be 
reciprocally required for efficient kinetochore recruitment 
(Taylor et al., 1998; Sharp­Baker and Chen, 2001; Chen, 2002; 
Meraldi et al., 2004; Vigneron et al., 2004; Logarinho et al., 
2008). An important conclusion from our analysis is that the in­
tegrity of the Bub3­binding region of Bub1 is important for the 
interaction of Bub1 with BubR1 and with kinetochores (Fig. 8 D).
The precise molecular mechanism underlying the inter­
action of Bub1–Bub3 with BubR1–Bub3 and with kinetochores is 
currently unclear (Fig. 8 E). Kinetochores are very complex and 
dynamic assemblies, whose most intriguing feature is the ability 
to regulate checkpoint signaling as a function of the progression 
of kinetochore–microtubule attachment. The feedback mecha­
nisms that couple the maturation of kinetochore–microtubule at­
tachment to checkpoint control are known only imperfectly. The 
Mad1–Mad2 complex, which plays an essential role in Mad2 
activation at the kinetochore (De Antoni et al., 2005), is progres­
sively removed from kinetochores via a dynein­dependent path­
way (Howell et al., 2001; Wojcik et al., 2001; Gassmann et al., 
2008). Forced retention of Mad1–Mad2 at kinetochores prevents 
checkpoint satisfaction despite the formation of a normal meta­
phase plate (Maldonado and Kapoor, 2011a). Thus, the removal 
of at least a subset of the checkpoint proteins from the kineto­
chore is a prerequisite for exiting mitosis.
Bub1 is also progressively removed from kinetochores 
upon microtubule attachment (Taylor et al., 2001; Famulski and 
Chan, 2007). How this is achieved at the molecular level is 
not known but worthy of further investigations. A fundamen­
tal emerging concept is that the KMN network complex plays 
a crucial role in relaying kinetochore–microtubule attachment 
to checkpoint silencing. This idea is corroborated by the obser­
vation that the KMN acts not only as the crucial microtubule­ 
binding moiety of the kinetochore but also as a recruitment 
platform for all known checkpoint proteins, excluding Aurora B 
(Santaguida and Musacchio, 2009). It is therefore from this 
platform that the checkpoint proteins have to be removed for 
checkpoint silencing to be achieved.
The Knl1 subunit is probably a focal point of this dynamic 
regulation. In the immediate vicinity of the Bub1 KI1 motif, 
Knl1 contains a bipartite binding region for the PP1 phospha­
tase (Fig. 1 A and Fig. 8 E; Liu et al., 2010). This region has also 
been implicated in microtubule binding (Pagliuca et al., 2009; 
Welburn et al., 2010). The RRVSF motif in the PP1­binding 
region is a target of the Aurora B kinase, and Aurora B phos­
phorylation antagonizes PP1 binding, limiting the timing of 
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sodium chloride, 20 mM Tris, pH 7.4, and 5 mM 2-mercaptoethanol). Histone 
H2A–containing fractions were then dialyzed first against 2 M NaCl, 10 mM 
Tris-HCl, pH 7.5, and 5 mM DTT and finally against 200 mM NaCl, 10 mM 
Tris-HCl, pH 7.5, and 1 mM DTT to achieve fully refolded conditions.
Kinase assays were performed in 30 µl reaction volume as described 
previously (Santaguida et al., 2010). In brief, reaction mixes contained 
50 µM ATP, 1 mM DTT, phosphatase inhibitor cocktail (Sigma-Aldrich), 
10 µCi -[32P]ATP, and 10 µM H2A histone as a substrate. His-Bub1–Bub3 
kinases were used at a concentration of 50 nM diluted in kinase buffer 
(50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 10 mM MgCl2, and 1 mM EDTA). 
2OH-BNPP1 inhibitor (a gift from K. Shokat, University of California, San 
Francisco, San Francisco, CA) was used at a final concentration of 5 µM. 
Knl1(150–250) peptide was expressed and purified as described in Protein 
expression and purification and used at the final concentration of 1.8 µM. 
For kinase immunoprecipitation followed by kinase assay, Flp-In T-REx 
cells were induced with doxycycline (see Cell culture and transfection) 
and lysed in lysis buffer (150 mM KCl, 75 mM Hepes, pH 7.5, 1.5 mM 
MgCl2, 10% glycerol, and 0.075% NP-40 supplemented with protease 
inhibitors cocktail [Protease Inhibitor Cocktail Set III]) and phosphatase 
inhibitors (PhosSTOP). Immunoprecipitation was performed as described 
in Immunoprecipitation and immunoblotting. Kinase reaction mixes were 
added to the immunoprecipitates, previously washed with kinase buffer, 
incubated for 1 h at 30°C, and quenched with SDS loading buffer. Proteins 
were resolved on a 14% SDS-PAGE. Incorporation of 32P was visualized 
by autoradiography.
Protein expression and purification
Sequences encoding Bub1(1–150), BubR1(1–204), Knl1(150–200), 
Knl1(201–250), and Knl1(150–250) were created by PCR amplification 
and subcloned in the first cassette of pGEX-6P-2rbs (Sironi et al., 2001). Site-
directed mutagenesis was performed with a mutagenesis kit (QuikChange) 
and used to generate mutants in the Bub1 and BubR1 expression constructs. 
All constructs were verified by sequencing.
Bacterial strain E. coli BL21(DE3)pLysS was used for expression of 
Bub1 and BubR1 constructs. Rosetta strain was used for expression of Knl1 
constructs. To express Bub1(1–150), BL21 cells were grown in Luria-Bertani 
medium at 37°C until an OD600 of 0.7. At this point, expression was 
induced with 0.3 mM IPTG, and cells were cultured at 20°C for 16 h before 
collection. The BubR1(1–204) construct was expressed in BL21(DE3)pLysS 
cells. Expression was induced with 0.2 mM IPTG at an OD600 of 0.7, 
and cells were further cultured at 25°C for 16 h. Rosetta cells carrying ex-
pression plasmids for Knl1(150–200), Knl1(201–250), or Knl1(150–250) 
were grown in Luria-Bertani medium at 37°C. Expression was induced with 
0.3 mM IPTG at an OD600 0.8, and cells were cultured at 22°C for 16 h 
before collection by centrifugation.
Cell pellets were resuspended in lysis buffer (50 mM Tris, 0.5% NP-40, 
150 mM NaCl, 2 mM EDTA, and 1 mM DTT, pH 7.4) supplemented with 
protease inhibitor cocktail (Protease Inhibitor Set III). After sonication, the 
cell lysate was cleared by high-speed centrifugation. The supernatant was 
collected and incubated with glutathione Sepharose 4 Fast Flow beads 
(GE Healthcare) at room temperature for 2 h. The Sepharose beads bound 
with GST-tagged protein constructs were collected by centrifugation and 
washed with 20 bed volumes PBS buffer followed by 5 bed volumes 
protease cleavage buffer (PreScission; 50 mM Tris, 150 mM NaCl, 1 mM 
EDTA, and 1 mM DTT). The beads were incubated with PreScission prote-
ase at a 200:1 ratio (estimated recombinant protein w/protease w) at 4°C 
overnight. The collected eluate was applied to a column (Superdex 75 
10/300; GE Healthcare) equilibrated in size-exclusion chromatography 
buffer (10 mM Na-phosphate and 150 mM NaCl, pH 7.4). Size-exclusion 
chromatography was performed at a flow rate of 0.5 ml/min, and the frac-
tions containing target proteins were collected, concentrated, flash frozen 
in liquid N2, and stored at 80°C.
Analytical size-exclusion chromatography
Analytical size-exclusion chromatography experiments were performed on 
a column (Superdex 75 10/300). All samples were eluted at 4°C in size-
exclusion chromatography buffer at a flow rate of 0.5 ml/min. Elution of 
proteins was monitored at 280 nm. To detect complex formation, different 
combination of proteins were mixed at a concentration of 5 µM in 600 µl, 
incubated at 4°C for >1 h, and then subjected to chromatography. Fractions 
were collected and analyzed by SDS-PAGE and Coomassie staining.
Fluorescence anisotropy
Fluorescence anisotropy measurements were performed with a micro-
plate reader (Infinite F200; Tecan) at 20°C. Fluorescein (5-FAM)-labeled 
Knl1(174–190) peptide (synthesized by Mimotopes), at a concentration 
with protease inhibitor cocktail [Protease Inhibitor Cocktail Set III; EMD]) and 
phosphatase inhibitors (PhosSTOP; Roche). For immunoprecipitation experi-
ments, extracts were precleared with a mixture of protein A–Sepharose 
(CL-4B; GE Healthcare) and protein G–Sepharose (rec-Protein G-Sepharose 4B 
Conjugate; Invitrogen) for 1 h at 4°C and centrifuged for 4 min at 4,000 rpm. 
Supernatants were then incubated with GFP-Traps (ChromoTek; 3 µl/mg 
of extract) for 2–4 h at 4°C. Immunoprecipitates were washed with lysis 
buffer and resuspended in sample buffer, boiled at 95°C for 5 min, and 
analyzed by SDS-PAGE and Western blotting.
The following antibodies were used for immunoblotting: anti-Actin 
(mouse monoclonal antibody AC-40; Sigma-Aldrich; working dilution of 
1:1,000), anti-GFP (in house made rabbit polyclonal antibody; working dilu-
tion of 1:400), anti-GFP (mouse monoclonal B-2, 9996; Roche; working 
dilution of 1:1,000), anti-Hec1 (human Ndc80; mouse clone 9G3.23; Gene-
Tex, Inc.; working dilution of 1:1,000), anti-Mis12 (in house made mouse 
monoclonal antibody; clone Q015; working dilution of 1:5), anti-KNL1 
(in house made rabbit polyclonal SI0788 antibody; working dilution of 
1:1,000), anti-Bub1 (rabbit polyclonal Ab9000; Abcam; working dilution of 
1:5,000), anti-BubR1 (mouse; BD; working dilution of 1:1,000), mouse 
anti-Bub3 (mouse; BD; working dilution of 1:1,000), antivinculin (mouse 
monoclonal antibody; clone hVIN-1; Sigma-Aldrich; working dilution of 
1:100,000), antiphospho–S10-H3 (rabbit polyclonal 06–570; Millipore; 
working dilution of 1:1,000). For Fig. 4 D, Fig. 6 A (top), and Fig. 7 A, 
blots were incubated with anti–mouse and anti–rabbit affinity-purified 
secondary antibodies with horseradish peroxidase conjugate (Bio-Rad 
Laboratories; working dilution of 1:10,000) detected with a Western blot-
ting system (ECL; GE Healthcare) with films or digital imaging (ChemiBIS 
3.2; DNR Bio-Imaging Systems). All other blots were incubated with anti–
mouse and anti–rabbit IRDye 680LT or IRDye 800CW secondary antibodies 
obtained from LI-COR Biosciences (working dilution of 1:10,000) and 
scanned with Odyssey 3.0 (LI-COR Biosciences).
Immunofluorescence
HeLa cells were plated onto coverslips pretreated with 15 µg/ml poly(d)lysine 
(Sigma-Aldrich). The day after, cells were transfected with the plasmids for 
48–68 h and treated with nocodazole for 6–10 h. Immunofluorescence 
was performed as described previously (Screpanti et al., 2011). Anti-
centromeric antibody (working dilution of 1:60 diluted in 2% BSA-PBS; 
Antibodies, Inc.) was incubated for 2 h to stain kinetochores. Anti–human 
Cy3- or DyLight 649–conjugated secondary antibodies (Jackson Immuno-
Research Laboratories, Inc.) were diluted at 1:100 in BSA 2%–PBS and 
incubated for 30 min. DAPI was used to stain the DNA. Coverslips were 
then mounted with Mowiol mounting media. Cells were imaged at room 
temperature using a confocal microscope (TCS SP2; Leica) equipped with 
a 63×, NA 1.4 objective lens using the LCS 3D software (Leica). Images 
in Fig. S3 (A and B) were acquired as z sections at 0.2442 µm and con-
verted into maximal intensity projections using ImageJ (National Institutes 
of Health). Intensities of kinetochore areas, from at least four cells per 
condition, were measured with ImageJ software and corrected for the 
mean intensity of nonkinetochore areas. Measurements were graphed 
with Excel (Microsoft) software.
In vitro kinase assays
Recombinant His-Bub1–Bub3 wild-type and kinase-dead kinases were ex-
pressed and purified from Sf9 insect cells infected with recombinant baculo-
viruses as previously described (Santaguida et al., 2010). In brief, Sf9 insect 
cells infected with recombinant baculoviruses were lysed in lysis buffer 
(50 mM Tris, pH 8.0, 300 mM NaCl, 5% glycerol, 1 mM -mercaptoethanol, 
and protease inhibitors [Protease Inhibitor Cocktail Set III, Calbiochem]). 
The complex was isolated on Ni-nitrilotriacetic acid beads, eluted with 
200 mM imidazole, dialyzed in 10 mM Tris HCl, pH 8.0, 100 mM NaCl, 
5% glycerol, and 1 mM DTT, and further purified by size-exclusion chro-
matography. Full-length H2A of Xenopus laevis was expressed in E. coli, 
purified under denaturing conditions, and refolded for being used as Bub1 
in vitro substrate following the original protocol (Luger et al., 1997) with 
small modifications. In brief, the bacterial lysate was spun for 30 min at 
4°C at 25,000 g twice. The inclusion body containing the pellet was then 
subjected to chemical lysis by adding 1 ml DMSO for 30 min at room tem-
perature followed by adding 30 ml of unfolding buffer (7 M guanidinium 
HCl, 20 mM Tris-HCl, pH 7.5, and 10 mM DTT) and incubated for 1 h at 
room temperature. Cell debris was removed by centrifugation at 4°C at 
25,000 g. The supernatant containing the unfolded proteins was dialyzed 
thoroughly against 7 M urea, 200 mM sodium chloride, 20 mM Tris, pH 7.4, 
and 5 mM 2-mercaptoethanol at 4°C. The dialyzed supernatant was then 
loaded onto a column (HiPrep SP FF 16/10 GE Healthcare), and the histone 
H2A was eluted with a linear gradient in high salt buffer (7 M urea, 2 M 
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of 40 nM, was mixed with increasing concentrations of Bub1(1–150) in 
PBS buffer, and reaction mixtures were incubated at 4°C for 1 h. 5-FAM– 
labeled synthetic peptide Knl1(210–226) (at a concentration of 10 nM) 
was mixed with BubR1(1–204). Fluorescein was excited with polarized 
light at 485 nm, and the emitted light was detected at 535 nm through 
both horizontal and vertical polarizers. The Kd was determined by fitting 
the fluorescence polarization data to the equation Pobs = Pmax[C]/([C] + Kd), 
in which Pobs is the observed fluorescence polarization signal, Pmax is the 
saturation value of polarization (with all the peptide in complex with the 
protein), and [C] is the protein concentration.
Crystallization and structure determination
Bub1(1–150) and Knl1(150–200) were mixed with molar ratio 1:1 and 
incubated on ice for 1 h and separated on a column (Superdex 75 10/300). 
The fractions containing the complex were collected, concentrated, flash 
frozen in liquid N2, and stored at 80°C. The complex was set for crystal-
lization using tris(2-carboxyethyl)phosphine as an antioxidant. Diffraction 
quality crystals were obtained by microseeding against 1.25 –1.3 M Na 
malonate, pH 6.0.
X-ray diffraction data were collected at the ID14-EH1 beamline at 
the European Synchrotron Radiation Facility (Grenoble, France). Data 
processing and reduction were performed using MOSFLM and SCALA 
from the CCP4 suite (Collaborative Computational Project, Number 4, 
1994), and data collection statistics are provided in Table 1. Four in-
dependent monomers were placed in the asymmetric unit by molecular 
replacement using the program PHASER (McCoy et al., 2007) and the 
known Bub1 model from S. cerevisiae (Protein Data Bank accession no. 
3ESL) as a search probe. Model optimization was performed by alter-
nating refinement cycles with the program REFMAC (Murshudov et al., 
1999) and phenix.refine from the PHENIX suite (Adams et al., 2010), 
and manual rebuilding was performed with COOT (Emsley et al., 2010) 
against a 2.6-Å dataset. The final model includes four Bub1 monomers 
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coordinates of the Bub1(1–150)–Knl1(150–200) complex is 4AIG.
Online supplemental material
Fig. S1 shows the expression levels of several Bub1 and BubR1 constructs 
discussed in this paper. Fig. S2 reports a detailed structural comparison of 
the complexes of the Bub1 and BubR1 TPRs with KI1 and KI2, respectively. 
Fig. S3 shows the localization pattern of single point mutants in the Bub1 TPR 
region. Fig. S4 shows additional kinase assays and loading controls for ex-
periments in Fig. 7. Fig. S5 complements Fig. 8 and shows additional localiza-
tion experiments as well as loading controls. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.201110013/DC1.
Table 2. Refinement statistics used in this paper
Variable Value
Unique reflectionsa 30,887
R factor 18.59
Rfree 24.36
Refined atoms
Protein non-H atoms 5,375
Solvent 120
r.m.s. deviations
Bond lengths (Å) 0.009
Bond angles 1.173
Ramachandran analysis 
Most favored (%) 92.8
Additionally allowed 6.5
Generously allowed 0.3
Disallowed 0.3
Rfree is the same for the test set (5% of the data). R factor = ∑hkl ||Fo|  k|Fc||/
∑hkl |Fo|, in which k is the scaling factor, Fc is the calculated amplitude of 
the structure factor, and Fo is the observed amplitude of the structure factor. 
ESRF, European Synchrotron Radiation Facility; r.m.s., root-mean-square.
aThis number does not include the free R set of reflections (5% of total reflections).
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